Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro

Natural compounds derived from plants have been an important source of numerous clinically useful anticancer agents. Nevertheless, limited studies indicate that xanthohumol (XN), a major prenylated flavonoid in hop plants (Humulus lupulus), may possess anticarcinogenic properties. The purpose of the present study was to clarify the antitumorigenic effects and the underlying mechanism of XN on breast cancer in vivo and in vitro. A 4T1 breast tumor mouse model was used in the present study to investigate XN suppression of tumor growth as detected by tumorigenicity assays in vivo. In addition, in vitro studies revealed that XN significantly decreased cell viability, induced G0/G1 cell cycle arrest and apoptosis in MCF-7 and MDA-MB-231 cells, as confirmed by an MTT assay, flow cytometry and western blot analysis, indicating anticarcinogenic activity of XN against breast cancer. Furthermore, immunohistochemistry was performed to confirm the inactivation of the Notch signaling pathway, Notch 1 and Ki-67, in vivo; consistently, XN caused decreased activation of the Notch signaling pathway and apoptotic regulators B-cell lymphoma-2 (Bcl-2), Bcl-extra large and caspase 3, as determined by western blot analysis in vitro. This study suggests that XN may potentially be useful as a chemopreventive agent during breast hyperplasia and carcinogenesis, acting via the regulation of Notch associated apoptotic regulators in vivo and in vitro.

[1]  C. Vanhove,et al.  Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma , 2016, The Journal of Nuclear Medicine.

[2]  W. Deng,et al.  Ligand-Independent Mechanisms of Notch Activity. , 2015, Trends in cell biology.

[3]  Y. Bignon,et al.  Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen , 2015, PloS one.

[4]  Benzhong Wang,et al.  Notch-1 promotes breast cancer cells proliferation by regulating LncRNA GAS5. , 2015, International journal of clinical and experimental medicine.

[5]  Shiying Yu,et al.  Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis , 2015, PloS one.

[6]  Ximing Xu,et al.  N6-substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells. , 2014, Cancer letters.

[7]  Yan Wang,et al.  Overexpressed ubiquitin ligase Cullin7 in breast cancer promotes cell proliferation and invasion via down-regulating p53. , 2014, Biochemical and biophysical research communications.

[8]  Li Zhang,et al.  Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo. , 2013, European journal of cancer.

[9]  J. Chen,et al.  PMS1077 Sensitizes TNF-α Induced Apoptosis in Human Prostate Cancer Cells by Blocking NF-κB Signaling Pathway , 2013, PloS one.

[10]  Yeh-long Chen,et al.  Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  P. Jolicoeur,et al.  Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells which can revert to bi-potential progenitors from which they arise , 2012, Oncogene.

[12]  Bin Bao,et al.  Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer , 2012, International journal of molecular sciences.

[13]  K. Roby,et al.  Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. , 2012, Gynecologic oncology.

[14]  Ronit Vogt Sionov,et al.  A Role for Bcl-2 in Notch1-Dependent Transcription in Thymic Lymphoma Cells , 2012, Advances in hematology.

[15]  Jack Cuzick,et al.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. , 2011, Journal of the National Cancer Institute.

[16]  F. Martel,et al.  In Vitro Studies on the Inhibition of Colon Cancer by Butyrate and Polyphenolic Compounds , 2011, Nutrition and cancer.

[17]  S. Sridhar,et al.  Notch Signaling Pathway as a Therapeutic Target in Breast Cancer , 2010, Molecular Cancer Therapeutics.

[18]  W. Huttner,et al.  Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. , 2009, Cell stem cell.

[19]  R. Coombes,et al.  Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells , 2009, British Journal of Cancer.

[20]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[21]  X. Qu,et al.  Cross-Talk Between Notch and EGFR Signaling in Human Breast Cancer Cells , 2009, Cancer investigation.

[22]  C. Calhau,et al.  Xanthohumol influences preadipocyte differentiation: implication of antiproliferative and apoptotic effects. , 2008, Journal of agricultural and food chemistry.

[23]  C. Sanders,et al.  Substrate specificity of γ-secretase and other intramembrane proteases , 2008, Cellular and Molecular Life Sciences.

[24]  Min-Zu Wu,et al.  The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1. , 2007, Carcinogenesis.

[25]  I. Shih,et al.  Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy: Figure 1. , 2007 .

[26]  C. Miranda,et al.  Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. , 2007, Cancer letters.

[27]  P. Nair,et al.  Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. , 2007, Gynecologic oncology.

[28]  J. Aster,et al.  The multifaceted role of Notch in cancer. , 2007, Current opinion in genetics & development.

[29]  R. Soares,et al.  Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells. , 2007, Clinical biochemistry.

[30]  Adam A. Margolin,et al.  NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth , 2006, Proceedings of the National Academy of Sciences.

[31]  H. Nozawa.  Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. , 2005, Biochemical and biophysical research communications.

[32]  C. Gerhäuser,et al.  Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. , 2005, Molecular nutrition & food research.

[33]  Hans Clevers,et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.

[34]  K. Raj,et al.  The role of Notch in tumorigenesis: oncogene or tumour suppressor? , 2003, Nature Reviews Cancer.

[35]  H. Bartsch,et al.  Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. , 2002, Molecular cancer therapeutics.

[36]  Freddy Radtke,et al.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation , 2001, The EMBO journal.

[37]  S. Artavanis-Tsakonas,et al.  Notch signaling: cell fate control and signal integration in development. , 1999, Science.

[38]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[39]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[40]  A. Chinnaiyan,et al.  Supplementary Figure S3 , 2012 .

[41]  Jung-Ae Kim,et al.  Geranyl derivative of phloroacetophenone induces cancer cell-specific apoptosis through Bax-mediated mitochondrial pathway in MCF-7 human breast cancer cells. , 2012, Biological & pharmaceutical bulletin.

[42]  B. A. Carter,et al.  Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group , 2012 .

[43]  R. Clarke,et al.  Breast stem cells and cancer. , 2006, Ernst Schering Foundation symposium proceedings.